PATH
Menu

Filter browse results

Total results with these characteristics: 36

Subject: Vaccines and immunization > Malaria

Page 1 of 2
Fighting Malaria Today and Tomorrow: PATH Works With Developing Countries to Achieve a Malaria-Free World

This fact sheet describes PATH's work to eliminate malaria, including expanding the use of lifesaving tools, identifying and developing better diagnostics and drugs, devising new strategies for malaria control, and accelerating the development of malaria vaccines.

Publication date: April 2014

Region: Global

Part of series: Areas of focus fact sheets

Malaria Vaccine Initiative Global Program Website

This website about PATH’s Malaria Vaccine Initiative (MVI) global program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2014

Region: Global

Part of series: Program websites

Malaria Vaccine Initiative Website

Launched in 2002, this website provides information on the Malaria Vaccine Initiative at PATH.

Publication date: 2014

Region: Global

Part of series: Websites

MVI Update

The PATH Malaria Vaccine Initiative (MVI) provides news and updates to collaborators and partners through MVI Update. Each issue opens with a letter from the director and provides articles about MVI’s work in malaria vaccine development and in preparing for vaccine availability and accessibility.

Publication date: 2014

Region: Global

Part of series: E-newsletters

Vaccine Resource Library Website

PATH’s Vaccine Resource Library (VRL) seeks to gather the world’s best immunization resources in a single, easy-to-use website. The VRL offers a wide variety of high-quality, scientifically accurate documents and links on specific diseases and topics in immunization. It is geared for health professionals in the developing and industrialized worlds, as well as for journalists, policymakers, community leaders, parents, and others interested in vaccine-related resources. The resources found on the VRL are collected from a variety of sources, including news media, scientific journals, and leaders in public health.

Publication date: 2014

Region: Global

Part of series: Websites

Increasing Access to Lifesaving Vaccines: PATH Closes the Immunization Gap Through Innovation and Collaboration

This fact sheet outlines PATH's work on vaccines and immunization. Topic areas include developing affordable vaccines, designing innovative vaccine technologies, and expanding uptake of existing vaccines. These efforts reduce the burden of malaria, meningitis, diarrheal disease, Japanese encephalitis, pneumococcal disease, influenza, rotavirus, polio, respiratory syncytial virus (RSV), and other infectious diseases in developing countries.

Publication date: December 2013

Region: Global

Part of series: Areas of focus fact sheets

PATH Today (Winter 2013)

This issue of PATH Today shares a breakthrough for a vaccine against Japanese encephalitis and the story of Dr. Nekoye Otsyula, a researcher on PATH's malaria vaccine trial. PATH donors Brian Arbogast and Valerie Tarico describe their approach to giving—supporting solutions that let people take care of themselves.

Publication date: December 2013

Region: Global

Part of series: PATH Today

2012 Annual Report: Innovation in Motion

PATH’s health solutions touched the lives of more than 118 million people around the world in 2012. Our 2012 annual report highlights our milestones in three focus areas: diarrheal disease and pneumonia; family health; and malaria. It also features innovations in technology development and country-based health programs, a financial summary, and information about our donors, leadership, and global presence.

Publication date: May 2013

Region: Global

Part of series: Annual reports

PATH Today (Spring 2013)

This issue of PATH Today describes PATH's multipronged approach to eliminating malaria in Africa and the development of semisynthetic artemisinin, a key ingredient in malaria treatment. It includes updates on PATH's work to prevent diarrhea in Cambodia and to diagnose cervical cancer. It also contains a profile of Dean Allen, CEO of McKinstry and PATH's board treasurer.

Publication date: May 2013

Region: Global

Part of series: PATH Today

Decade of Vaccines Special Supplement

The journal Vaccine published a special supplement on the Decade of Vaccines Global Vaccine Action Plan (GVAP) that features articles by PATH contributors and others on the GVAP strategic objectives and the opportunities and challenges associated with its implementation. The 27 articles cover a range of related topics, including vaccine development, financing, access, delivery, and health impact. More than 100 authors contributed to the supplement representing a variety of international and developing-country stakeholders, from civil society and academia to vaccine manufacturers and policymakers.

Author: Glassman A, Zoloa JI, Duran D, et al

Publication date: April 2013

Region: Global

A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants

This article, published in the New England Journal of Medicine (NEJM), reports results from a pivotal, large-scale Phase 3 trial of RTS,S/AS01 malaria vaccine. When compared to immunization with a control vaccine, infants (aged 6 to 12 weeks at first vaccination) vaccinated with RTS,S had one-third fewer episodes of both clinical and severe malaria and had similar reactions to the injection. In this trial, RTS,S demonstrated an acceptable safety and tolerability profile. The abstract of this article is available through the NEJM by clicking on "Visit web page" below, or for free access to the full lenth article please visit malariavaccine.org and click on "Read the NEJM article."

Publication date: December 2012

Region: Africa

The PATH Malaria Vaccine Initiative

The PATH Malaria Vaccine Initiative (MVI) is a vaccine development program of PATH. This fact sheet provides an overview of MVI's history, mission, vision, and work.

Publication date: November 2012

Region: Global

Summary of Vaccine Stability Data

These documents provide stability data as of November 2012 on commonly used, licensed vaccines and stability data as of May 2012 from available data on novel, investigational vaccine formulations. Data are sorted by vaccine in a table format.

Publication date: November 2012

Region: Global

Strengthening National Regulatory Capacity: PATH Supports Countries to Ensure Health Products Are Safe, Effective, and Swiftly Delivered

Global investments to strengthen regulatory capacity in developing countries help ensure desperately needed medical products are delivered, thereby improving health and equipping countries with the expertise and infrastructure to make important health decisions for years to come.

Publication date: July 2012

Region: Global

Global Vaccine Action Plan: 2011-2020

The Global Vaccine Action Plan (GVAP)—endorsed by the 194 Member States of the World Health Assembly in May 2012—is a roadmap to prevent millions of deaths by 2020 through more equitable access to vaccines for people in all communities. The GVAP aims to strengthen routine immunization, introduce new and improved vaccines, and advance research and development for the next generation of vaccines and technologies.

Author: Decade of Vaccines Collaboration

Publication date: May 2012

Region: Global

Innovating to Improve Health: PATH Develops and Delivers Novel Solutions for Those Who Need Them Most

This fact sheet provides an overview of PATH's work to develop and deliver innovative health solutions for those who need them most. These solutions range from developing and introducing affordable, appropriate technologies to creating conditions that lead to widespread use of proven methods.

Publication date: April 2012

Region: Global

10 Tips for Successful Malaria Vaccine Advocacy

This booklet presents advocacy tips, success stories, and examples of efforts to bridge the worlds of science and policymaking and to help ensure that policymakers at national, regional, and international levels have the information needed to make timely and informed decisions as soon as a first malaria vaccine becomes available for use.

Publication date: February 2012

Region: Africa

Country Planning for Health Interventions Under Development: Lessons From the Malaria Vaccine Decision-Making Framework and Implications for Other New Interventions

This paper describes research into the anticipated processes and data needed to inform decision-making on malaria vaccines, the most advanced of which is still in phase 3 trials.

Author: Brooks A, Ba-Nguz A

Publication date: February 2012

Region: Africa

PATH Today (Winter 2011)

This issue of PATH Today features our work in vaccines, with a focus on how PATH is making "hidden solutions" available, and describes lifesaving changes in South Africa's infant feeding policies. It also includes news from our malaria and meningitis work, an announcement of PATH's new blog, and a profile of PATH donor Lora Kaiser.

Publication date: December 2011

Region: Global

Part of series: PATH Today

First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children

A malaria vaccine, deployed in combination with current malaria-control tools, could play an important role in the future control and eventual elimination of malaria in Africa. This article, published in the New England Journal of Medicine, reports the initial results of an ongoing phase 3 trial of RTS,S/AS01 being conducted at 11 centers in seven African countries.

Publication date: November 2011

Region: Africa

Page 1 of 2